Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 916 AL 930

Huntington disease: Implications for practice

Cummins A, Eggert J, Pruitt R, Collins JS.

Nurse Pract. 2011 Feb;36(2):41-7. doi: 10.1097/01.NPR.0000392796.01760.e2.

Postural deficits in Huntington's disease when performing motor skills involved in daily living

Panzera R, Salomonczyk D, Pirogovosky E, Simmons R, Goldstein J, Corey-Bloom J, Gilbert PE.

Gait Posture. 2011 Mar;33(3):457-61. doi: 10.1016/j.gaitpost.2010.12.025. Epub 2011 Jan 20.

Astrocyte elevated gene-1 (AEG-1): A multifunctional regulator of normal and abnormal physiology

Yoo BK, Emdad L, Lee SG, Su ZZ, Santhekadur P, Chen D, Gredler R, Fisher PB, Sarkar D.

Pharmacol Ther. 2011 Apr;130(1):1-8. doi: 10.1016/j.pharmthera.2011.01.008. Epub 2011 Jan 20.

Functional and systems biology approaches to Huntington's disease

González-Couto E.

Brief Funct Genomics. 2011 May;10(3):109-14. doi: 10.1093/bfgp/elr003. Epub 2011 Jan 27.

In silico discovery and experimental validation of new protein-protein interactions

van Haagen HH, 't Hoen PA, de Morrée A, van Roon-Mom WM, Peters DJ, Roos M, Mons B, van Ommen GJ, Schuemie MJ.

Proteomics. 2011 Mar;11(5):843-53. doi: 10.1002/pmic.201000398. Epub 2011 Jan 31.

The importance of integrating basic and clinical research toward the development of new therapies for Huntington disease

Munoz-Sanjuan I, Bates GP.

J Clin Invest. 2011 Feb;121(2):476-83. doi: 10.1172/JCI45364. Epub 2011 Feb 1.

Brain networks in Huntington disease

Eidelberg D, Surmeier DJ.

J Clin Invest. 2011 Feb;121(2):484-92. doi: 10.1172/JCI45646. Epub 2011 Feb 1.

Energy deficit in Huntington disease: why it matters

Mochel F, Haller RG.

J Clin Invest. 2011 Feb;121(2):493-9. doi: 10.1172/JCI45691. Epub 2011 Feb 1.

Oligonucleotide therapeutic approaches for Huntington disease

Sah DW, Aronin N.

J Clin Invest. 2011 Feb;121(2):500-7. doi: 10.1172/JCI45130. Epub 2011 Feb 1.

Structural requirements to obtain highly potent and selective 18 kDa Translocator Protein (TSPO) Ligands

Taliani S, Pugliesi I, Da Settimo F.

Curr Top Med Chem. 2011;11(7):860-86. doi: 10.2174/156802611795165142.

Benign hereditary chorea: an update

Inzelberg R, Weinberger M, Gak E.

Parkinsonism Relat Disord. 2011 Jun;17(5):301-7. doi: 10.1016/j.parkreldis.2011.01.002. Epub 2011 Feb 3.

Validating the use of M4-BAC-GFP mice as tissue donors in cell replacement therapies in a rodent model of Huntington's disease

Döbrössy M, Klein A, Janghra N, Nikkhah G, Dunnett SB.

J Neurosci Methods. 2011 Apr 15;197(1):6-13. doi: 10.1016/j.jneumeth.2011.01.015. Epub 2011 Feb 3.

[Huntington's chorea mimicking adult attention deficit hyperactivity disorder]

Kraemer M, Haertig S, Hill A, Uekermann J, Wiltfang J, Kis B.

Nervenarzt. 2011 Mar;82(3):360-2. doi: 10.1007/s00115-011-3251-5.

Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease

Ehrnhoefer DE, Sutton L, Hayden MR.

Neuroscientist. 2011 Oct;17(5):475-92. doi: 10.1177/1073858410390378. Epub 2011 Feb 10.

Preaortic left primitive iliac vein: two case studies

Rhissassi B, Bahnini A, Kieffer E.

Ann Vasc Surg. 2011 Feb;25(2):269.e1-3. doi: 10.1016/j.avsg.2010.10.004.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias